narcan® naloxone hcl nasal spray 4 mg drug facts
a0ebc83d-2892-40de-bc0a-775ce90b30db
34390-5
HUMAN OTC DRUG LABEL
Drug Facts
Composition & Product
Identifiers & Packaging
Purpose
Emergency treatment of opioid overdose
Description
Naloxone Hydrochloride 4 mg
Medication Information
Uses
-
•to “revive” someone during an overdose from many prescription pain medications or street drugs such as heroin
-
•this medicine can save a life
Purpose
Emergency treatment of opioid overdose
Directions
NARCAN®
Naloxone HCl Nasal Spray 4 mg
|
Emergency Treatment of Opioid Overdose
Important:
|
|
|
Step 1: CHECK if you suspect an overdose:
|
|
|
Step 2: Give 1st dose in the nose
|
|
|
Step 3: CALL 911
|
|
|
Step 4: WATCH & GIVE
|
|
|
Step 5: STAY
|
For opioid emergencies, call 911. For questions on NARCAN, call 1-844-4NARCAN (1-844-462-7226) or go to www.narcan.com.
©2023 Emergent Devices Inc. EMERGENT® and NARCAN® are registered trademarks of Emergent BioSolutions Inc, or its subsidiaries.
Other Information
-
•store at room temperature or refrigerated, between 2°C to 25°C (36°F to 77°F)
-
•do not freeze
-
•avoid excessive heat above 40°C (104°F)
-
•protect from light
-
•the product is packaged in individually-sealed blisters.
Do not use if the blister is open or torn, or if the device appears damaged.
Inactive Ingredients
benzalkonium chloride, edetate disodium, hydrochloric acid, sodium chloride, water
Description
Naloxone Hydrochloride 4 mg
Questions?
Call 1-844-4NARCAN (1-844-462-7226) or go to www.narcan.com
Warning
-
•When using this product some people may experience symptoms when they wake up, such as, shaking, sweating, nausea, or feeling angry. This is to be expected.
Active Ingredient (in Each Spray)
Naloxone Hydrochloride 4 mg
Package/label Principal Display Panel – Carton Label
NARCAN®
Naloxone HCl Nasal Spray 4 mg
Emergency Treatment of Opioid Overdose
Original
Prescription
Strength
Easy to Use
Can Save a Life
Designed to
Rapidly Reverse
the Effects of a
Life-Threatening
Opioid Emergency
2 Single-Dose Nasal Spray Devices
0.003 fl oz (0.1 mL) each
For use in
nose only
Distributed by Emergent Devices Inc.
Plymouth Meeting, PA 19462 USA
©2023 Emergent Devices Inc. Plymouth Meeting, PA.
All rights reserved.
NARCAN® is a registered trademark of Emergent Operations
Ireland Limited.
NDC 69547-627-02
Package/label Principal Display Panel 4 Mg Vial Package
NDC 69547-627-02
NARCAN®
Naloxone HCl Nasal Spray 4 mg
Emergency Treatment of Opioid Overdose
-
•For use in the nose only
-
•Do not test nasal spray device before use
-
•1 nasal spray device contains 1 dose of medicine
-
•Each device sprays 1 time only
-
•Store at room temperature or refrigerated,
between 2°C to 25°C (36°F to 77°F) -
•Do not freeze
-
•Avoid excessive heat above 40°C (104°F)
Lot XXXXXX EXP YYYY-MMM
Distributed by Emergent Devices Inc.
Plymouth Meeting, PA 19462 USA A1160
Package/label Principal Display Panel – Front and Back Label
NARCAN®
Naloxone HCl Nasal Spray 4 mg
141357
A1158
FOR USE IN THE NOSE ONLY
NDC 69547-627-02
A1159
Distributed by Emergent Devices, Inc.
Plymouth Meeting, PA 19462, USA
141358
Lot XXXXXX
EXP YYYY-MMM
Structured Label Content
Uses
-
•to “revive” someone during an overdose from many prescription pain medications or street drugs such as heroin
-
•this medicine can save a life
Purpose
Emergency treatment of opioid overdose
Directions
NARCAN®
Naloxone HCl Nasal Spray 4 mg
|
Emergency Treatment of Opioid Overdose
Important:
|
|
|
Step 1: CHECK if you suspect an overdose:
|
|
|
Step 2: Give 1st dose in the nose
|
|
|
Step 3: CALL 911
|
|
|
Step 4: WATCH & GIVE
|
|
|
Step 5: STAY
|
For opioid emergencies, call 911. For questions on NARCAN, call 1-844-4NARCAN (1-844-462-7226) or go to www.narcan.com.
©2023 Emergent Devices Inc. EMERGENT® and NARCAN® are registered trademarks of Emergent BioSolutions Inc, or its subsidiaries.
Other Information
-
•store at room temperature or refrigerated, between 2°C to 25°C (36°F to 77°F)
-
•do not freeze
-
•avoid excessive heat above 40°C (104°F)
-
•protect from light
-
•the product is packaged in individually-sealed blisters.
Do not use if the blister is open or torn, or if the device appears damaged.
Inactive Ingredients
benzalkonium chloride, edetate disodium, hydrochloric acid, sodium chloride, water
Questions?
Call 1-844-4NARCAN (1-844-462-7226) or go to www.narcan.com
Warning
-
•When using this product some people may experience symptoms when they wake up, such as, shaking, sweating, nausea, or feeling angry. This is to be expected.
Active Ingredient (in Each Spray) (Active ingredient (in each spray))
Naloxone Hydrochloride 4 mg
Package/label Principal Display Panel – Carton Label (Package/Label Principal Display Panel – Carton Label)
NARCAN®
Naloxone HCl Nasal Spray 4 mg
Emergency Treatment of Opioid Overdose
Original
Prescription
Strength
Easy to Use
Can Save a Life
Designed to
Rapidly Reverse
the Effects of a
Life-Threatening
Opioid Emergency
2 Single-Dose Nasal Spray Devices
0.003 fl oz (0.1 mL) each
For use in
nose only
Distributed by Emergent Devices Inc.
Plymouth Meeting, PA 19462 USA
©2023 Emergent Devices Inc. Plymouth Meeting, PA.
All rights reserved.
NARCAN® is a registered trademark of Emergent Operations
Ireland Limited.
NDC 69547-627-02
Package/label Principal Display Panel 4 Mg Vial Package (Package/Label Principal Display Panel - 4 mg Vial Package)
NDC 69547-627-02
NARCAN®
Naloxone HCl Nasal Spray 4 mg
Emergency Treatment of Opioid Overdose
-
•For use in the nose only
-
•Do not test nasal spray device before use
-
•1 nasal spray device contains 1 dose of medicine
-
•Each device sprays 1 time only
-
•Store at room temperature or refrigerated,
between 2°C to 25°C (36°F to 77°F) -
•Do not freeze
-
•Avoid excessive heat above 40°C (104°F)
Lot XXXXXX EXP YYYY-MMM
Distributed by Emergent Devices Inc.
Plymouth Meeting, PA 19462 USA A1160
Package/label Principal Display Panel – Front and Back Label (Package/Label Principal Display Panel – Front and Back Label)
NARCAN®
Naloxone HCl Nasal Spray 4 mg
141357
A1158
FOR USE IN THE NOSE ONLY
NDC 69547-627-02
A1159
Distributed by Emergent Devices, Inc.
Plymouth Meeting, PA 19462, USA
141358
Lot XXXXXX
EXP YYYY-MMM
Advanced Ingredient Data
Raw Label Data
All Sections (JSON)
Additional Information
Back to search View SPL set listing Open on DailyMed ↗
Source: dailymed · Ingested: 2026-02-15T12:01:13.242813 · Updated: 2026-03-14T23:01:17.657881